ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years
An interim analysis of the OLYMPIA long-term extension study to be presented as a late-breaking abstract at the XIV…
